- Global Pharma News & Resources

Ascites Pipeline Insight Report 2018 -

The "Ascites - Pipeline Insight, 2018" drug pipelines has been added to's offering.

'Ascites - Pipeline Insight, 2018' report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Ascites development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Scope of the report:

  • The report provides a snapshot of the pipeline development for the Ascites
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Ascites
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Ascites
  • The report also covers the dormant and discontinued pipeline projects related to the Ascites

Companies Mentioned

  • Inkine Pharmaceutical
  • BioVie Inc
  • Sequana Medical AG
  • Jiangsu Simcere Pharmaceutical Co.
  • Alfa Wassermann S.p.A.

For more information about this drug pipelines report visit

View source version on

Editor Details

Last Updated: 13-Dec-2018